JARDIANCE MET 12.5MG/500MG – 10 TABLETS

Description

JARDIANCE MET 12.5MG/500MG is a combined medication that includes empagliflozin, an SGLT2 inhibitor, and metformin, a biguanide. This combination works synergistically to lower blood sugar levels by improving insulin sensitivity and reducing glucose reabsorption in the kidneys. JARDIANCE MET 12.5MG/500MG is prescribed for type 2 diabetes management, offering a comprehensive approach to glucose control and overall metabolic health.

Usage Instructions:
Dosage: Take one JARDIANCE MET 12.5MG/500MG tablet twice daily, with or without food.
Administration: Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
Consistency: Use the medication regularly at the same times each day to maintain stable blood sugar levels.
Missed Dose: If you miss a dose, take it as soon as you remember. If it is close to the time of your next dose, skip the missed dose. Do not double up on doses.
Medicinal Advantages:
JARDIANCE MET 12.5MG/500MG effectively manages type 2 diabetes by combining the glucose-lowering effects of empagliflozin and metformin. Empagliflozin helps lower blood sugar by preventing glucose reabsorption in the kidneys, while metformin improves insulin sensitivity and decreases glucose production in the liver. This combination helps achieve better glycemic control and supports overall metabolic health.

Mechanism of Action:
JARDIANCE MET 12.5MG/500MG works through a dual mechanism:

Empagliflozin: Inhibits the SGLT2 protein in the kidneys, reducing glucose reabsorption and increasing glucose excretion in the urine.
Metformin: Enhances insulin sensitivity in muscle cells and reduces glucose production in the liver. This combination results in more effective blood sugar control and improved insulin function.
Off-Label Uses:
While JARDIANCE MET 12.5MG/500MG is primarily used for managing type 2 diabetes, it may also be explored off-label for other conditions related to metabolic syndrome or insulin resistance, as determined by a healthcare provider.

Expert Advice:
For optimal results with JARDIANCE MET 12.5MG/500MG, follow the prescribed dosage and maintain regular monitoring of blood glucose levels. Combine medication with a balanced diet and exercise regimen for enhanced effectiveness. Regular check-ups with your healthcare provider are crucial for managing diabetes effectively and adjusting treatment as necessary.

Precautions:
Kidney Function: Monitor kidney function regularly, as empagliflozin may impact renal health. Avoid use if kidney function is significantly impaired.
Lactic Acidosis: Metformin can cause lactic acidosis in rare cases. Contact your healthcare provider if you experience symptoms such as unusual fatigue or difficulty breathing.
Pregnancy and Lactation: Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, to discuss the safety and potential risks of JARDIANCE MET 12.5MG/500MG.
Storage Conditions:
Store JARDIANCE MET 12.5MG/500MG at room temperature, away from moisture and direct sunlight. Keep out of reach of children and use before the expiration date.

FAQs:
Q1: What conditions does JARDIANCE MET 12.5MG/500MG treat? A1: JARDIANCE MET 12.5MG/500MG is used to manage type 2 diabetes by lowering blood sugar levels and improving metabolic health.

Q2: How should I take JARDIANCE MET 12.5MG/500MG? A2: Take one tablet twice daily with or without food, swallowing it whole with water.

Q3: Can JARDIANCE MET 12.5MG/500MG be used during pregnancy? A3: Consult your healthcare provider before using JARDIANCE MET 12.5MG/500MG if you are pregnant or breastfeeding to assess safety and risks.

Q4: How should I store JARDIANCE MET 12.5MG/500MG? A4: Store at room temperature, away from moisture and sunlight. Keep out of reach of children and use before the expiration date.